Viewing nowCombinationLevacame tablet 10/80 milligrams
Lercanidipine Hydrochloride 10mg · Valsartan 80mg
Tablet · Prescription medication · Combination
LG Chem, Ltd.

MFDS item code 201308391 · Approved 2013.07.25 · Insurance code 668902550
Treatment of essential hypertension not controlled with lercanidipine monotherapy
Used to control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with lercanidipine.
The recommended dose is 1 tablet once daily, taken with water at least 15 minutes before a meal. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using lercanidipine. However, if blood pressure is not controlled, switching directly to this medicine may be considered as follows. - 10/80 mg: For patients whose blood pressure is not adequately controlled with lercanidipine 10 mg. - 10/160 mg: For patients whose blood pressure is not adequately controlled with lercanidipine 10 mg or this medicine 10/80 mg. - 20/160 mg: For patients whose blood pressure is not adequately controlled with this medicine 10/160 mg. ° Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment; however, caution is required when increasing the daily dose of lercanidipine to 20mg. This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. ° Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg, and caution is required when increasing the daily dose of lercanidipine to 20mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. ° Elderly patients: In patients aged 65 years or older, start treatment at a low dose and administer with caution while monitoring the patient's condition.
° Pediatric patients: Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Pregnant women or those who might become pregnant, as well as nursing mothers, should not take this medication. Patients with severely impaired liver function, liver cirrhosis, or bile duct obstruction, and those with certain genetic disorders should not take this medication. It is also not advisable for patients with significantly impaired heart and kidney function, patients undergoing hemodialysis, and children or adolescents under 18 years old. Elderly patients or those with mildly impaired liver function should start at a low dose and be monitored closely throughout treatment. Patients with high blood potassium levels or at risk of hyperkalemia should be cautious when taking this medication. This medication has a strong blood pressure-lowering effect, so dizziness or fainting may occur due to a rapid drop in blood pressure when first taken. Particularly, patients who are taking diuretics or are in a state of fluid depletion should be more careful. Sudden discontinuation of this medication may worsen symptoms, so it should be tapered off gradually. Interactions may occur when taken with other antihypertensive medications or certain drugs, so consulting a healthcare professional is essential. In case of overdose, severe hypotension, decreased consciousness, heart problems, etc., may occur, and immediate medical attention should be sought. This medication should be kept out of reach of children, and transferring it to another container may lead to accidents, so caution is advised.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is recommended to keep it at room temperature between 1 to 30 degrees Celsius. This helps to maintain the medication’s effectiveness for a longer period.
Bright yellowish-brown round film-coated tablets
100 tablets (10 tablets/PTP x 10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLercanidipine Hydrochloride 10mg · Valsartan 80mg
Tablet · Prescription medication · Combination
LG Chem, Ltd.
CombinationLercanidipine Hydrochloride 20mg · Valsartan 160mg
Tablet · Prescription medication · Combination
LG Chem, Co., Ltd.
CombinationLercanidipine Hydrochloride 10mg · Valsartan 160mg
Tablet · Prescription medication · Combination
LG Chem, Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.